820 related articles for article (PubMed ID: 21644496)
1. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
Feldman SR; Fleischer AB
Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma.
Fuchs A; Marmur E
Dermatol Surg; 2007 Sep; 33(9):1099-101. PubMed ID: 17760601
[TBL] [Abstract][Full Text] [Related]
4. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
5. Topical management of actinic keratosis and field cancerisation.
Stockfleth E
G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
[TBL] [Abstract][Full Text] [Related]
6. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
Deltondo JA; Helm KF
G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
[TBL] [Abstract][Full Text] [Related]
7. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
8. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model.
Zalaudek I; Giacomel J; Schmid K; Bondino S; Rosendahl C; Cavicchini S; Tourlaki A; Gasparini S; Bourne P; Keir J; Kittler H; Eibenschutz L; Catricalà C; Argenziano G
J Am Acad Dermatol; 2012 Apr; 66(4):589-97. PubMed ID: 21839538
[TBL] [Abstract][Full Text] [Related]
9. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
10. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
11. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
Berman B; Cohen DE; Amini S
Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
[TBL] [Abstract][Full Text] [Related]
12. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
13. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
14. Morphologic grading and treatment of facial actinic keratosis.
Zalaudek I; Piana S; Moscarella E; Longo C; Zendri E; Castagnetti F; Pellacani G; Lallas A; Argenziano G
Clin Dermatol; 2014; 32(1):80-7. PubMed ID: 24314380
[TBL] [Abstract][Full Text] [Related]
15. Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Terushkin V; Braga JC; Dusza SW; Scope A; Busam K; Marghoob AA; Gill M; Halpern AC
Dermatol Surg; 2010 Oct; 36(10):1514-20. PubMed ID: 20698872
[TBL] [Abstract][Full Text] [Related]
16. Premalignant and early squamous cell carcinoma.
Butani AK; Arbesfeld DM; Schwartz RA
Clin Plast Surg; 2005 Apr; 32(2):223-35. PubMed ID: 15814119
[TBL] [Abstract][Full Text] [Related]
17. The importance of early diagnosis and treatment of actinic keratosis.
Rigel DS; Stein Gold LF
J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S20-7. PubMed ID: 23228303
[TBL] [Abstract][Full Text] [Related]
18. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
[TBL] [Abstract][Full Text] [Related]
19. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
20. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
